The Role of Corticotropin-releasing Factor and Corticosterone in Stress- and Cocaine-induced Relapse to Cocaine Seeking in Rats

Overview

Journal J Neurosci

Specialty Neurology

Date 1998 Jul 3

PMID 9651233

Citations 135

Authors

S Erb

Y Shaham

J Stewart

Affiliations

Soon will be listed here.

Abstract

We have shown previously that footshock stress and priming injections of cocaine reinstate cocaine seeking in rats after prolonged drug-free periods (Erb et al., 1996). Here we examined the role of brain corticotropin-releasing factor (CRF) and the adrenal hormone corticosterone in stress- and cocaine-induced reinstatement of cocaine seeking in rats. The ability of footshock stress and priming injections of cocaine to induce relapse to cocaine seeking was studied after intracerebroventricular infusions of the CRF receptor antagonist D-Phe CRF12-41, after adrenalectomy, and after adrenalectomy with corticosterone replacement. Rats were allowed to self-administer cocaine (1.0 mg/kg/infusion, i.v) for 3 hr daily for 10-14 d and were then placed on an extinction schedule during which saline was substituted for cocaine. Tests for reinstatement were given after intermittent footshock (10 min; 0.5 mA) and after priming injections of saline and cocaine (20 mg/kg, i.p.). Footshock reinstated cocaine seeking in both intact animals and animals with corticosterone replacement but not in adrenalectomized animals. The CRF receptor antagonist D-Phe CRF12-41 blocked footshock-induced reinstatement at all doses tested in both intact animals and animals with corticosterone replacement. Reinstatement by priming injections of cocaine was only minimally attenuated by adrenalectomy and by pretreatment with D-Phe CRF12-41. These data suggest that brain CRF plays a critical role in stress-induced, but only a modulatory role in cocaine-induced, reinstatement of cocaine seeking. Furthermore, the data show that although reinstatement of cocaine seeking by footshock stress requires minimal, basal, levels of corticosterone, stress-induced increases in corticosterone do not play a role in this effect.

Citing Articles

Sex-specific effects of chronic stress prior to cocaine exposure on cue- vs drug-induced relapse after prolonged abstinence.

Morales-Silva R, Perez-Perez Y, Alvarado-Torres J, Rivera-Aviles N, Rodriguez-Torres G, Gelpi-Dominguez U Behav Brain Res. 2024; 474:115197.

PMID: 39128627 PMC: 11804798. DOI: 10.1016/j.bbr.2024.115197.

Corticotropin releasing factor and drug seeking in substance use disorders: Preclinical evidence and translational limitations.

Mantsch J Addict Neurosci. 2022; 4.

PMID: 36531188 PMC: 9757758. DOI: 10.1016/j.addicn.2022.100038.

Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review.

Karimi-Haghighi S, Chavoshinezhad S, Mozafari R, Noorbakhsh F, Borhani-Haghighi A, Haghparast A Cell Mol Neurobiol. 2022; 43(2):649-682.

PMID: 35461410 PMC: 11415174. DOI: 10.1007/s10571-022-01223-6.

Factors modulating the incubation of drug and non-drug craving and their clinical implications.

Venniro M, Reverte I, Ramsey L, Papastrat K, DOttavio G, Milella M Neurosci Biobehav Rev. 2021; 131:847-864.

PMID: 34597716 PMC: 8931548. DOI: 10.1016/j.neubiorev.2021.09.050.

Consideration of sex as a biological variable in the translation of pharmacotherapy for stress-associated drug seeking.

Martin E, Doncheck E, Reichel C, McRae-Clark A Neurobiol Stress. 2021; 15:100364.

PMID: 34345636 PMC: 8319013. DOI: 10.1016/j.ynstr.2021.100364.

References

Lavicky J, Dunn A . Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem. 1993; 60(2):602-12. DOI: 10.1111/j.1471-4159.1993.tb03191.x. View

Chen Y, Mansbach R, Winter S, Brooks E, Collins J, Corman M . Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist. J Med Chem. 1997; 40(11):1749-54. DOI: 10.1021/jm960861b. View

Erb S, Shaham Y, Stewart J . Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology (Berl). 1996; 128(4):408-12. DOI: 10.1007/s002130050150. View

Shaham Y, Stewart J . Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology (Berl). 1995; 119(3):334-41. DOI: 10.1007/BF02246300. View

Pechnick R . Effects of opioids on the hypothalamo-pituitary-adrenal axis. Annu Rev Pharmacol Toxicol. 1993; 33:353-82. DOI: 10.1146/annurev.pa.33.040193.002033. View

Piazza P, Rouge-Pont F, Deroche V, Maccari S, Simon H, Le Moal M . Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci U S A. 1996; 93(16):8716-20. PMC: 38739. DOI: 10.1073/pnas.93.16.8716. View

Makino S, Gold P, Schulkin J . Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res. 1994; 640(1-2):105-12. DOI: 10.1016/0006-8993(94)91862-7. View

Swanson L, SIMMONS D . Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J Comp Neurol. 1989; 285(4):413-35. DOI: 10.1002/cne.902850402. View

Makino S, Gold P, Schulkin J . Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res. 1994; 657(1-2):141-9. DOI: 10.1016/0006-8993(94)90961-x. View

10.

Piazza P, Le Moal M . Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol. 1996; 36:359-78. DOI: 10.1146/annurev.pa.36.040196.002043. View

11.

Stewart J . Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav. 1984; 20(6):917-23. DOI: 10.1016/0091-3057(84)90017-0. View

12.

Meyer J, Micco D, Stephenson B, Krey L, McEwen B . Subcutaneous implantation method for chronic glucocorticoid replacement therapy. Physiol Behav. 1979; 22(5):867-70. DOI: 10.1016/0031-9384(79)90330-5. View

13.

Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob G . Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci. 1995; 15(8):5439-47. PMC: 6577636. View

14.

Jaffe J, Cascella N, Kumor K, Sherer M . Cocaine-induced cocaine craving. Psychopharmacology (Berl). 1989; 97(1):59-64. DOI: 10.1007/BF00443414. View

15.

Dunn A, Berridge C . Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res Brain Res Rev. 1990; 15(2):71-100. DOI: 10.1016/0165-0173(90)90012-d. View

16.

Piazza P, Maccari S, Deminiere J, Le Moal M, Mormede P, Simon H . Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci U S A. 1991; 88(6):2088-92. PMC: 51174. DOI: 10.1073/pnas.88.6.2088. View

17.

Ahmed S, Koob G . Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology (Berl). 1997; 132(3):289-95. DOI: 10.1007/s002130050347. View

18.

Goeders N, Guerin G . Role of corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology. 1996; 64(5):337-48. DOI: 10.1159/000127137. View

19.

Kosten T, Rounsaville B, KLEBER H . A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry. 1986; 43(8):733-8. DOI: 10.1001/archpsyc.1986.01800080019003. View

20.

Self D, Barnhart W, Lehman D, Nestler E . Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science. 1996; 271(5255):1586-9. DOI: 10.1126/science.271.5255.1586. View